Krediet T G, van Lelyveld N, Vijlbrief D C, Brouwers H A A, Kramer W L M, Fleer A, Gerards L J
Department of Neonatology, Wilhelmina Children's Hospital, University Medical Center, Utrecht, The Netherlands.
Acta Paediatr. 2003 Oct;92(10):1180-2.
The incidence of necrotizing enterocolitis (NEC) strongly increased in an neonatal intensive care unit (NICU) in 1997 and 1998 compared with previous years, which coincided with increased incidence of nosocomial sepsis. Specific risk factors related to this NICU and a possible relationship between NEC and nosocomial sepsis were studied retrospectively, including all patients with NEC since 1990 and matched controls.
Clinical and bacteriological data from the period before the development of NEC and a similar period for the controls were collected retrospectively and corrected for birthweight and gestational age. Statistical analysis was performed by a stepwise regression model.
Data of 104 neonates with NEC and matched controls were analysed. The median day of onset of NEC was 12 d (range 1-63 d). Significant risk factors for NEC were: insertion of a peripheral artery catheter [odds ratio (OR) 2.3, 95% confidence interval (95% CI) 1.3-3.9] and a central venous catheter (OR 5.6, 95% CI 3.1-10.1), colonization with Klebsiella sp. (OR 3.4, 95% CI 1.5-7.5) and Escherichia coli (OR 2.1, 95% CI 1.0-4.5), and the occurrence of sepsis, in particular due to coagulase-negative staphylococci (OR 2.6, 95% CI 1.4-5.1). The risk for NEC was decreased after the early use (< 48 h after birth) of amoxicillin-clavulanate and gentamicin (OR 0.3, 95% CI 0.2-0.6).
Insertion of central venous and peripheral arterial catheters is positively associated with NEC, as is colonization with the Gram-negative bacilli Klebsiella and E. coli and the occurrence of sepsis, particularly due to coagulase-negative staphylococci. Early treatment with amoxicillin-clavulanate and gentamicin is negatively associated with NEC and may be protective against NEC.
与前几年相比,1997年和1998年某新生儿重症监护病房(NICU)坏死性小肠结肠炎(NEC)的发病率大幅上升,这与医院感染性败血症发病率的增加相吻合。对该NICU相关的特定危险因素以及NEC与医院感染性败血症之间可能存在的关系进行了回顾性研究,研究对象包括自1990年以来所有患NEC的患者及其匹配对照。
回顾性收集NEC发病前阶段以及对照的类似阶段的临床和细菌学数据,并根据出生体重和胎龄进行校正。采用逐步回归模型进行统计分析。
分析了104例患NEC的新生儿及其匹配对照的数据。NEC发病的中位天数为12天(范围1 - 63天)。NEC的显著危险因素包括:外周动脉导管置入[比值比(OR)2.3,95%置信区间(95%CI)1.3 - 3.9]和中心静脉导管(OR 5.6,95%CI 3.1 - 10.1)、克雷伯菌属定植(OR 3.4,95%CI 1.5 - 7.5)和大肠杆菌定植(OR 2.1,95%CI 1.0 - 4.5),以及败血症的发生,尤其是由凝固酶阴性葡萄球菌引起的败血症(OR 2.6,95%CI 1.4 - 5.1)。出生后早期(<48小时)使用阿莫西林 - 克拉维酸和庆大霉素后,NEC的风险降低(OR 0.3,95%CI 0.2 - 0.6)。
中心静脉导管和外周动脉导管的置入与NEC呈正相关,革兰阴性杆菌克雷伯菌和大肠杆菌的定植以及败血症的发生(尤其是由凝固酶阴性葡萄球菌引起的败血症)也与NEC呈正相关。早期使用阿莫西林 - 克拉维酸和庆大霉素治疗与NEC呈负相关,可能对NEC有保护作用。